Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
DOI: 10.1039/D6CC90175A
(Correction)
Chem. Commun., 2026, Advance Article
Correction: Phenylboronic acid-modified nanoparticles for cancer treatment
Siming Zhoua,
Liqun Daia,
Lili Panb,
Guohua Shen*b and
Zhiyong Qian*a
aDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. E-mail: zhiyongqian@scu.edu.cn
bDepartment of Nuclear Medicine, Laboratory of Clinical Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. E-mail: shengh1990@126.com
Received
14th May 2026
, Accepted 14th May 2026
First published on 8th June 2026
Abstract
Correction for ‘Phenylboronic acid-modified nanoparticles for cancer treatment’ by Siming Zhou et al., Chem. Commun., 2025, 61, 4595–4605, DOI: 10.1039/D4CC06730D.
The authors regret that the caption to Fig. 1, also used as the graphical abstract image, did not correctly indicate that it was adapted from a figure originally published in Acc. Chem. Res., 2019, 52(11), 3108–3119, cited as ref. 13 in the original article.1 The updated figure and caption are shown below.
 | ||
| Fig. 1 A schematic illustration of boronic acids acting as ligands for diols such as (A) reduced pH, (B) ROS, (C) reacting with diols, and (D) sialic acid. This figure was adapted from ref. 13 with permission. Copyright 2019, American Chemical Society. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
References
- A. Stubelius, S. Lee and A. Almutairi, Acc. Chem. Res., 2019, 52, 3108–3119 Search PubMed.
| This journal is © The Royal Society of Chemistry 2026 |